Effect of CD4+CD25+ and CD4+CD25- T regulatory cells on the generation of cytolytic T cell response to a self but human tumor-associated epitope in vitro

被引:37
作者
Chattopadhyay, S [1 ]
Mehrotra, S [1 ]
Chhabra, A [1 ]
Hegde, U [1 ]
Mukherji, B [1 ]
Chakraborty, NG [1 ]
机构
[1] Univ Connecticut, Sch Med, Farmington, CT 06030 USA
关键词
D O I
10.4049/jimmunol.176.2.984
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD4(+) T cells naturally expressing CD25 molecules (natural T regulatory cells (Tregs)) have a role in maintaining self tolerance and in regulating responses to infectious agents, transplantation Ags, and tumor Ags. CD4(+) Tregs induced from CD4(+)CD25(-) precursors (induced Tregs) also regulate immune responses in the periphery. However, which of these Tregs is a major impediment in generating antitumor CTL responses is not clear. We show that although the CD4(+)CD25(+) subsets isolated from peripheral blood-derived lymphocytes do suppress the proliferation of CD4(+)CD25(-) effector T cells, they do not suppress the activation and expansion of the self but melanoma-associated, melanoma Ag-reactive T cell 1 (MART-1)(27-35)-specific CD8(+) T cells stimulated by the respective peptide-loaded matured dendritic cells in vitro. The CD4+CD25- counterparts, in contrast, lead to the generation of CD25(+) glucocorticoid-inducible TNFR+-Forkhead/winged helix transcription factor(+) populations and efficiently suppress the activation and expansion of the MART-1(27-35) epitope-specific CTLs. Our data suggest that when CTL precursors are optimally stimulated, natural Tregs are not a formidable constraint toward generating a robust antitumor CTL response, but induced Tregs could be.
引用
收藏
页码:984 / 990
页数:7
相关论文
共 60 条
[1]   Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen [J].
Akbari, O ;
DeKruyff, RH ;
Umetsu, DT .
NATURE IMMUNOLOGY, 2001, 2 (08) :725-731
[2]   In vivo instruction of suppressor commitment in naive T cells [J].
Apostolou, I ;
von Boehmer, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (10) :1401-1408
[3]   Inhibition of human CD4+CD25+high regulatory T cell function [J].
Baecher-Allan, C ;
Viglietta, V ;
Hafler, DA .
JOURNAL OF IMMUNOLOGY, 2002, 169 (11) :6210-6217
[4]  
BERENDT MJ, 1980, J EXP MED, V151, P69, DOI 10.1084/jem.151.1.69
[5]   Human CD4+CD25+ regulatory cells have marked and sustained effects on CD8+ T cell activation [J].
Câmara, NOS ;
Sebille, F ;
Lechler, RI .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (12) :3473-3483
[6]   CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-γ-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination [J].
Casares, N ;
Arribillaga, L ;
Sarobe, P ;
Dotor, J ;
de Cerio, ALD ;
Melero, I ;
Prieto, J ;
Borrás-Cuesta, F ;
Lasarte, JJ .
JOURNAL OF IMMUNOLOGY, 2003, 171 (11) :5931-5939
[7]  
CHAKRABORTY NG, 1990, J IMMUNOL, V145, P2359
[8]  
Chakravarti A, 1999, GENOME ANAL, V4, P1
[9]   Regulatory T cells and tumor immunity [J].
Chattopadhyay, S ;
Chakraborty, NG ;
Mukherji, B .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2005, 54 (12) :1153-1161
[10]   Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivoi [J].
Chen, ML ;
Pittet, MJ ;
Gorelik, L ;
Flavell, RA ;
Weissleder, R ;
von Boehmer, H ;
Khazaie, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (02) :419-424